Boston Scientific
BSX
BSX
550 hedge funds and large institutions have $31.5B invested in Boston Scientific in 2017 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 179 increasing their positions, 227 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more call options, than puts
Call options by funds: $39.8M | Put options by funds: $39.8M
1% less funds holding
Funds holding: 555 → 550 (-5)
21% less repeat investments, than reductions
Existing positions increased: 179 | Existing positions reduced: 227
Holders
550
Holding in Top 10
11
Calls
$39.8M
Puts
$39.8M
Top Buyers
| 1 | +$2.28B | |
| 2 | +$350M | |
| 3 | +$326M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$119M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$87.1M |
Top Sellers
| 1 | -$168M | |
| 2 | -$137M | |
| 3 | -$115M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$96.3M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$94.7M |